Clear Harbor Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Clear Harbor Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-36,400	Closed	-$149K	–	455
2022 Q1	$149K	Hold	36,400	–	–	0.02%	362
2021 Q4	$130K	Buy	36,400 +10,400	+40%	+$36.4K	0.01%	377
2021 Q3	$95K	Buy	26,000 +5,000	+24%	+$20.2K	﹤0.01%	366
2021 Q2	$92K	Buy	+21,000	New	+$85.5K	0.01%	354
2020 Q4	–	Sell	-3,000	Closed	-$8.1K	–	790
2020 Q3	$8.1K	Buy	+3,000	New	+$8.3K	﹤0.01%	616

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clear Harbor Asset Management's ATRS Position: Q2 2022 in Review

Clear Harbor Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 36,400 shares — an estimated $149K sold.

Clear Harbor Asset Management first reported a position in ATRS in Q3 2020 and held it in 5 quarters. The position peaked at $149K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Clear Harbor Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Clear Harbor Asset Management sold 36,400 Antares Pharma, Inc. shares in Q2 2022, an estimated $149K.
Clear Harbor Asset Management first reported a position in Antares Pharma, Inc. in Q3 2020 and held it in 5 quarters.
Clear Harbor Asset Management's Antares Pharma, Inc. position peaked at $149K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Clear Harbor Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.